Corvus Pharmaceuticals Inc (CRVS) — Long-term Investment Intensity
Corvus Pharmaceuticals Inc (CRVS) has a Long-term Investment Intensity of 4.1% as of March 2026. Long-term investments of $10.50 Million represent 4.1% of total assets of $253.19 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check CRVS cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Corvus Pharmaceuticals Inc Long-term Investment Intensity (2020–2025)
This chart shows how Corvus Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the intensity stands at 4.1%, reflecting long-term investments of $10.50 Million against total assets of $253.19 Million USD. Explore CRVS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Corvus Pharmaceuticals Inc (2020–2025)
The table below presents the year-by-year Long-term Investment Intensity for Corvus Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Corvus Pharmaceuticals Inc stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 15.5% | $10.99 Million | $71.12 Million | ▼ -2.7 pp |
| 2024 | 18.2% | $12.54 Million | $68.91 Million | ▼ -17.2 pp |
| 2023 | 35.4% | $16.12 Million | $45.55 Million | ▲ +3.3 pp |
| 2022 | 32.1% | $21.88 Million | $68.24 Million | ▲ +0.8 pp |
| 2021 | 31.3% | $34.27 Million | $109.45 Million | ▼ -12.2 pp |
| 2020 | 43.5% | $37.23 Million | $85.53 Million | — |